The effect of loteprednol suspension eye drops after corneal transplantation

Abstract Background To compare the effect of loteprednol suspension eye drops after corneal transplantation with the effect of prednisolone acetate eye drops. Methods A total of 234 patients (234 eyes) who underwent penetrating keratoplasty (PKP) and lamellar keratoplasty (LKP) were retrospectively...

Full description

Bibliographic Details
Main Authors: Yingxin Chen, Xifei Wang, Minghong Gao, Ruiyao Gao, Lixin Song
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-021-01982-8
id doaj-2647020f3fc846598d9b81deca92f46a
record_format Article
spelling doaj-2647020f3fc846598d9b81deca92f46a2021-05-30T11:24:27ZengBMCBMC Ophthalmology1471-24152021-05-012111810.1186/s12886-021-01982-8The effect of loteprednol suspension eye drops after corneal transplantationYingxin Chen0Xifei Wang1Minghong Gao2Ruiyao Gao3Lixin Song4Department of Ophthalmology, The General Hospital of Northern Theater CommandDepartment of Ophthalmology, The General Hospital of Northern Theater CommandDepartment of Ophthalmology, The General Hospital of Northern Theater CommandDepartment of Ophthalmology, The General Hospital of Northern Theater CommandDepartment of Dermatology, The General Hospital of Northern Theater CommandAbstract Background To compare the effect of loteprednol suspension eye drops after corneal transplantation with the effect of prednisolone acetate eye drops. Methods A total of 234 patients (234 eyes) who underwent penetrating keratoplasty (PKP) and lamellar keratoplasty (LKP) were retrospectively included. Patients who received 1 % prednisolone acetate eye drops were defined as 1 % prednisolone acetate eye drop group (n = 96), and patients who received 0.5 % loteprednol suspension eye drops were defined as 0.5 % loteprednol suspension eye drop group (n = 138). Results 35 cases in 1 % prednisolone acetate eye drops group and 27 cases in 0.5 % loteprednol suspension eye drops group developed corticosteroid-induced ocular hypertension, and were defined as prednisolone acetate group and loteprednol group. No significant differences were observed in the average intraocular pressure (IOP) at 1 week, 1 month, 3 months or 12 months postoperatively. There were significant differences in the average IOP between the two groups at 6 months postoperatively (P = 0.001). There were no significant differences in the average best corrected visual acuity (BCVA) at 1, 3 and 12 months postoperatively between two groups. The average 6-month postoperative BCVA was significantly higher in the prednisolone acetate group than the loteprednol group (P < 0.05). There were no significant differences in the postoperative graft rejection rates between the two groups (P > 0.05). Conclusions 0.5 % loteprednol suspension eye drops may be considered for long-term use after corneal transplantation.https://doi.org/10.1186/s12886-021-01982-8Corticosteroid-induced ocular hypertensionCorneal transplantation1 % prednisolone acetate eye drops0.5 % loteprednol suspension eye drops
collection DOAJ
language English
format Article
sources DOAJ
author Yingxin Chen
Xifei Wang
Minghong Gao
Ruiyao Gao
Lixin Song
spellingShingle Yingxin Chen
Xifei Wang
Minghong Gao
Ruiyao Gao
Lixin Song
The effect of loteprednol suspension eye drops after corneal transplantation
BMC Ophthalmology
Corticosteroid-induced ocular hypertension
Corneal transplantation
1 % prednisolone acetate eye drops
0.5 % loteprednol suspension eye drops
author_facet Yingxin Chen
Xifei Wang
Minghong Gao
Ruiyao Gao
Lixin Song
author_sort Yingxin Chen
title The effect of loteprednol suspension eye drops after corneal transplantation
title_short The effect of loteprednol suspension eye drops after corneal transplantation
title_full The effect of loteprednol suspension eye drops after corneal transplantation
title_fullStr The effect of loteprednol suspension eye drops after corneal transplantation
title_full_unstemmed The effect of loteprednol suspension eye drops after corneal transplantation
title_sort effect of loteprednol suspension eye drops after corneal transplantation
publisher BMC
series BMC Ophthalmology
issn 1471-2415
publishDate 2021-05-01
description Abstract Background To compare the effect of loteprednol suspension eye drops after corneal transplantation with the effect of prednisolone acetate eye drops. Methods A total of 234 patients (234 eyes) who underwent penetrating keratoplasty (PKP) and lamellar keratoplasty (LKP) were retrospectively included. Patients who received 1 % prednisolone acetate eye drops were defined as 1 % prednisolone acetate eye drop group (n = 96), and patients who received 0.5 % loteprednol suspension eye drops were defined as 0.5 % loteprednol suspension eye drop group (n = 138). Results 35 cases in 1 % prednisolone acetate eye drops group and 27 cases in 0.5 % loteprednol suspension eye drops group developed corticosteroid-induced ocular hypertension, and were defined as prednisolone acetate group and loteprednol group. No significant differences were observed in the average intraocular pressure (IOP) at 1 week, 1 month, 3 months or 12 months postoperatively. There were significant differences in the average IOP between the two groups at 6 months postoperatively (P = 0.001). There were no significant differences in the average best corrected visual acuity (BCVA) at 1, 3 and 12 months postoperatively between two groups. The average 6-month postoperative BCVA was significantly higher in the prednisolone acetate group than the loteprednol group (P < 0.05). There were no significant differences in the postoperative graft rejection rates between the two groups (P > 0.05). Conclusions 0.5 % loteprednol suspension eye drops may be considered for long-term use after corneal transplantation.
topic Corticosteroid-induced ocular hypertension
Corneal transplantation
1 % prednisolone acetate eye drops
0.5 % loteprednol suspension eye drops
url https://doi.org/10.1186/s12886-021-01982-8
work_keys_str_mv AT yingxinchen theeffectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT xifeiwang theeffectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT minghonggao theeffectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT ruiyaogao theeffectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT lixinsong theeffectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT yingxinchen effectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT xifeiwang effectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT minghonggao effectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT ruiyaogao effectofloteprednolsuspensioneyedropsaftercornealtransplantation
AT lixinsong effectofloteprednolsuspensioneyedropsaftercornealtransplantation
_version_ 1721420337504059392